Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Hydrogen Sulfide Promotes TAM-M1 Polarization through Activating IRE-1α Pathway via GRP78 S-Sulfhydrylation to against Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 24, 2024
Retraction Notice to: miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα.
Journal: Molecular therapy. Nucleic acids
Published: June 27, 2022
Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Journal: Cell death & disease
Published: January 26, 2022
Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.
Journal: Frontiers in immunology
Published: November 02, 2021
Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.
Journal: Pathology oncology research : POR
Published: August 31, 2020
Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer.
Journal: Briefings in bioinformatics
Published: July 30, 2020
lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration.
Journal: Molecular therapy. Nucleic acids
Published: May 31, 2020
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
Journal: Journal of cellular and molecular medicine
Published: September 20, 2019
SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Journal: Journal of translational medicine
Published: May 09, 2019
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Journal: Cell death & disease
Published: December 19, 2018
Last Updated: 09/26/2026